About the company
AstraZeneca is an international, science-led biopharmaceutical company. Its work covers the discovery, development, clinical investigation and commercialisation of medicines. The company’s portfolio spans primary care, specialist treatment and rare diseases, bringing together different areas of pharmaceutical expertise.
AstraZeneca operates through research centres in several countries and a network of scientific partnerships. A central part of its approach is to understand the biological mechanisms underlying disease and use that knowledge to develop new therapeutic approaches.
Key areas of activity
Its main therapy areas are oncology; cardiovascular, renal and metabolic diseases; respiratory medicine and immunology; infectious disease; and rare disease. Research addresses existing medical needs while also exploring new biological targets, treatment combinations and opportunities for more precisely targeted medicines.
Alongside scientific development, AstraZeneca works on manufacturing and supply chains, access to healthcare and the resilience of health systems. These activities support its work across the medicine lifecycle, from research and clinical development to delivery and ongoing patient care.
Partnership with Zeytun
AstraZeneca is among the strategic and commercial partners of Zeytun Pharmaceuticals. This cooperation forms part of our international partnership portfolio. For further information about the partnership and related products, please contact the Zeytun Pharmaceuticals team.